Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.01SPGP 1.21ZUQ.TO 1.52NVDA 7.26GL 0.69MRK -4.15IEMG 1.84GEV 38.41
Patheon (PTI.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Patheon (PTI.TO)

0.00
-0.00 (0.00%)
6 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
SELL

Patheon(PTI.TO)

Jun 16, 2004
Bite the bullet, and move on.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$10.84

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Patheon(PTI.TO)

Jun 03, 2004
Could be a speculative buy at $11.35. If it breaks down through that price, it will go lower.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$11.80

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

May 31, 2004
The 200 day moving average cut the stock a couple of days ago and had decent volume indicating a breakout story. A lot of good technical things are happening.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
Owned
Unlock Rating
$13.28

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

May 31, 2004
Has disappointed three quarters in a row. Sit on the sidelines. Lots of time to buy this name once they turn around some of their problem areas.
Photo of Andrew McCreathAndrew McCreath
No
Unlock Rating
$13.28

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

May 14, 2004
Encountered trouble about 5/6 quarters ago when they bought a factory in Cincinnati and had trouble getting a going. Last quarter was good and is expecting the next quarter to be good. A bit of a bargain at this price.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$11.90

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Apr 28, 2004
Sort of a sector bet in pharmaceuticals. Seems to be at the bottom of a growth channel.
Photo of Bill CarriganBill Carrigan
Owned
Unlock Rating
$11.21

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Patheon(PTI.TO)

Apr 27, 2004
A little disappointed in the current price. Have been longtime supporters. Like the segment they are in and the management. Encouraged by the last quarter and the order book.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$11.29

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

Mar 30, 2004
(Past top pick Feb 9/ 2004 up 2%) Still like company, well managed. Profitable. 3x book value.
Photo of Michael SprungMichael Sprung
Owned
Unlock Rating
$11.14

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 17, 2004
Tried to break through the $17 level several times but couldn't make it. Has a falling 200 day moving average.
Photo of Ron MeiselsRon Meisels
No
Unlock Rating
$11.80

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 04, 2004
A great drug manufacturing stock that has had some problems. Stronger Canadian dollar has hurt.
Photo of Gavin GrahamGavin Graham
Owned
Unlock Rating
$11.44

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Mar 04, 2004
They execute their business plan very well. One of the premier manufacturers of drugs. Selling at not unreasonable prices.
Photo of Michael SprungMichael Sprung
Owned
Unlock Rating
$11.44

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 03, 2004
The chart doesn't look good. It's broken some pretty important longer-term technical patterns. $8 is probably a reasonable short-term target on the down side but it could go lower. The technical chart is really weak.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
No
Unlock Rating
$9.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Patheon(PTI.TO)

Mar 03, 2004
It's going to have a couple of tough quarters. Worth a look at the $8/9 range.
Photo of John ZechnerJohn Zechner
No
Unlock Rating
$9.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Mar 01, 2004
Has been in a long downward trend and keeps getting sold off day by day. Still buying for new clients as it's a well-managed company in a good sector.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$10.11

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Feb 20, 2004
Likes their business model. Have had it tough lately. Have been buying capacity and have not been able to fill it and get the kind of efficiency that they like. Attractive price.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. Sc
Owned
Unlock Rating
$10.63

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 76 to 90 of 194 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.75$36.5
ET -0.16$18.91
MAIR 0$
RKLB 6.86$109.25
SESG-O 0$

Today's Top Picks

HMP.TO 0.01$9.76
SPGP 1.21$121.6
ZUQ.TO 1.52$108.99
NVDA 7.26$212.45
GL 0.69$167.45

Popular Articles

Latest Sell Signals

PRGO -0.29$10.7
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica